CALDAN THERAPEUTICS LIMITED

⚰️Wound downliquidation

SC515558 · ltd · incorporated 2015-09-14

Investment thesis

Company liquidation — not a live target.

Why interesting: Historical record only; useful for precedent research.

Why risky: Not transactable.

Opportunity decay

approaching window · 12-months

Approaching a transaction window — refinance or sale event plausible in the next 12 months.

· Oldest live charge 9.8y old — refinance window within 12 months

🔒Estimated value

—

Upgrade to see

Turnover

—

not disclosed

Net worth

—

book net assets

Opportunity

36/100

Watch

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: Research and experimental development on biotechnology

Sector: Professional, scientific & technical

Investor take

Pass (distressed without resilience)

Distressed unclear — structural issues outweigh the discount.

Opportunity 36/100 (watch), bankability 30/100. Strong seller-intent signal (68/100, director aged 73). Asset purchase likely safer than share purchase given structural signals. Biggest value-creation lever: File overdue accounts. Clears statutory overdue flag — immediate bankability uplift for refinance conversations. Most likely exit: distressed disposal / insolvency (65/100). Current lenders should be on immediate intervention.

🏦

Refinance opportunity

2 live charges · 2 lenders · oldest 9.8y

50/100

clean up first

Refinance viable after a tidy-up — address the highlighted items first.

· Oldest live charge is 9.8 years old — likely at or near maturity.
· Two lenders — manageable, but coordination required.
· Legal-friction score 35/100 — workable, but lender will want more DD.

Data confidence

Overall: medium (58/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

No iXBRL financials extracted

Lenders & charges

2 charges (2/2 with lender, 2/2 with type)

Directors & officers

11 officers (5 active, 11 linked, 11 with DOB)

Ownership & PSC

1 active PSC(s) of 3 total, 3 with control declared

Director network

4 connected companies via shared directors

Filing history

73 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

36/100Watch

PassWatchWorth a lookStrongExceptional

Not actionable now, but monitor — distressed, succession, or structural changes could flip this into a real opportunity.

Business quality

Concerning — overdue filings or status flags present.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Multiple red flags — proceed with caution.

Signal strength

100

Good data coverage for analysis.

Recent activity

Last 30 days

filings

Last 90 days

filing

• 1 insolvency

Last 180 days

filing

• 1 insolvency

Counts from Companies House filing history.

Corporate timeline (43 events)Click to expand

2026-04-30
⚠️
liquidation-voluntary-creditors-return-of-final-meeting-scotland
insolvency · LIQ14(Scot)
2025-02-26
📄
mortgage-satisfy-charge-full
mortgage · MR04
2025-02-26
🔓
Charge satisfied #2
2024-11-07
📍
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2024-10-01
📄
resolution
resolution · RESOLUTIONS
2024-01-09
📄
accounts-with-accounts-type-full
accounts · AA
2023-11-22
📄
appoint-person-director-company-with-name-date
officers · AP01
2023-11-22
📄
termination-director-company-with-name-termination-date
officers · TM01
2023-11-15
➕
GOUGH, Lori Krim, Dr appointed
director
2023-11-15
➖
STEINHAGEN, Henning Klaus-Willi Christian, Dr resigned
director
2023-09-04
📄
termination-director-company-with-name-termination-date
officers · TM01
2023-08-31
➖
DUGDALE-BRADLEY, Linda Anne, Dr resigned
director
2023-08-31
📄
mortgage-satisfy-charge-full
mortgage · MR04
2023-08-31
🔓
Charge satisfied #1
2023-08-30
📄
mortgage-create-with-deed-with-charge-number-charge-creation-date
mortgage · MR01
2023-08-22
🔒
Charge registered #2
Lender: Hsbc Innovation Banking
2023-01-20
📄
capital-allotment-shares
capital · SH01
2023-01-16
📄
capital-allotment-shares
capital · SH01
2022-12-19
📄
accounts-with-accounts-type-full
accounts · AA
2022-06-17
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC05
2022-06-16
📄
termination-director-company-with-name-termination-date
officers · TM01
2022-05-31
➖
ARMSTRONG, Frank, Dr resigned
director
2022-05-16
📄
capital-allotment-shares
capital · SH01
2021-12-07
📄
accounts-with-accounts-type-small
accounts · AA
2021-04-27
📄
appoint-person-director-company-with-name-date
officers · AP01
2021-04-27
📄
appoint-person-director-company-with-name-date
officers · AP01
2021-04-26
📄
termination-director-company-with-name-termination-date
officers · TM01
2021-04-26
📄
termination-director-company-with-name-termination-date
officers · TM01
2021-04-22
➕
CANNING, Mary Eugenie, Dr appointed
director
2021-04-22
➕
DUGDALE-BRADLEY, Linda Anne, Dr appointed
director
2021-04-22
➖
ROPER, Elizabeth Ann, Dr resigned
director
2021-03-29
➖
DALRYMPLE, Michael Alexander, Doctor resigned
director
2019-07-31
➕
PAYTON, Mark Anthony, Dr appointed
director
2019-07-31
➖
FINAN, Peter Michael, Dr resigned
director
2019-07-31
➕
STEINHAGEN, Henning Klaus-Willi Christian, Dr appointed
director
2019-06-19
➕
DALRYMPLE, Michael Alexander, Doctor appointed
director
2016-08-25
🔒
Charge registered #1
Lender: Silicon Valley Bank
2016-03-08
➕
ARMSTRONG, Frank, Dr appointed
director
2015-11-09
➕
FINAN, Peter Michael, Dr appointed
director
2015-10-09
➕
ROPER, Elizabeth Ann, Dr appointed
director
2015-09-14
🏢
Company incorporated
As CALDAN THERAPEUTICS LIMITED
2015-09-14
➕
MILLIGAN, Graeme appointed
director
2015-09-14
➕
ULVEN, Trond appointed
director

Owner dependency

55/100

Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS

-5 active directors: Broader management team in place — suggests transferable governance.
+Founder age: Director aged approximately 73 — succession pressure is live.

Succession & seller-readiness

60/100

Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS

primaryFounder aged 70+: Senior director is approximately 73 years old. Natural succession window is now.

Red flags

4 high ·

Accounts overdue

high

Statutory accounts have not been filed by their due date. Can indicate admin breakdown, cash preservation, or deliberate delay.

Evidence: Next due: 2025-06-30

Confirmation statement overdue

high

Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal.

Evidence: Next due: 2025-06-26

Company in liquidation

high

Company is actively being wound up. Not a going concern.

1 insolvency-related filing on record

high

Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding.

Evidence: 2026-04-30: liquidation-voluntary-creditors-return-of-final-meeting-scotland

Group structure

Epidarex Capital Ii Lp holds 25-50% — a significant corporate investor but not a controlling parent.

🏛️

Epidarex Capital Ii Lp

Corporate parent · holds 25-50% shares

significant stake

⬇

CALDAN THERAPEUTICS LIMITED

This company · SC515558

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner

Name	Shares	Voting rights	Nature of control	Notified
Epidarex Capital Ii Lp Corporate entity	25–50%	25–50%	25-50% shares · 25-50% voting · firm interest	06/04/2016

2 historic (ceased) PSCs

Scottish Enterpriseceased 06/04/2016· 25-50% shares · firm interest
Epidarex Capital Partners Limitedceased 06/04/2016· 25-50% shares

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · PA postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
STEWART SHAW HOLDINGS LIMITED→ SC080687 · est 1982	£1.09M £800.5k–£1.37M	—	—	89	43y	85	75y
WEST HOLIDAYS LIMITED→ SC714316 · est 2021	£74.8k £55.1k–£94.5k	£198.8k	—	300	4y	93	48y
HEWITT ACCOUNT MANAGEMENT LIMITED→ SC693563 · est 2021	£71.3k £52.5k–£90.1k	£28.6k	—	200	5y	84	48y
POD SUBSEA CONTRACTORS LIMITED→ SC666683 · est 2020	£6.8k £5.0k–£8.6k	£4.2k	—	100	5y	86	58y
FORBES LESLIE NETWORK LIMITED→ SC148828 · est 1994	—	—	—	14	32y	83	62y
HEBRIDEAN WHALE AND DOLPHIN TRUST LIMITED→ SC172338 · est 1997 · no financials extracted	—	—	—	—	29y	83	79y
MACFARLANE YOUNG LIMITED→ SC332280 · est 2007	—	—	£146.8k	—	18y	83	62y
RSVP DESIGN LIMITED→ SC253981 · est 2003	—	—	£31.6k	—	22y	83	71y
STIRLING & MAIR LIMITED→ SC261547 · est 2004	—	—	£184.0k	—	22y	83	61y
ALISTAIR BROWN LIMITED→ SC243272 · est 2003	—	—	£11.0k	—	23y	82	82y
ASCOG LIMITED→ SC244061 · est 2003	—	—	£143.0k	—	23y	82	77y
CASTLETON HOLDINGS LIMITED→ SC246219 · est 2003	—	—	—	0	23y	82	76y

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

12 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusliquidation

Typeltd

Incorporated2015-09-14

Jurisdictionscotland

Primary SIC72110 — Research and experimental development on biotechnology

Registered office

7 St James Terrace

Lochwinnoch Road

Kilmacolm

PA13 4HB

Filing status

Accounts

Next due: 2025-06-30OVERDUE

Last made up to: 2023-09-30

Confirmation statement

Next due: 2025-06-26OVERDUE

Last: 2024-06-12